NSAID Effects on Clinical and Imaging Breast Biomarkers

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 114 participants.

Also called NCT01761877

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 114 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01761877
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01761877. Non-randomized; no masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2019-02-07 (actual). Results posted on 2023-02-10.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
NSAID Effects on Clinical and Imaging Breast Biomarkers
Condition
Inflammation
Condition
Cancer
Condition
Pain
Condition
Hypertension
Intervention (Drug)
Sulindac
Lead sponsor
Stony Brook University (class: other)

Record details

Record id
cardio:ct-nct01761877
Content hash
2359b679acbf4c5bc3344b446ab419b2d7af932db63b2a5d50e0a2b533db21b7